CIMB IB Research upgrades Hovid, target price 32 sen
KUALA LUMPUR (Aug 11): CIMB IB Research has upgraded Hovid Bhd to a “Hold” at 33 sen with an unchanged target price of 32 sen and said it thinks the worst is over for the stock, with stronger sales post the reissuance of its manufacturing licences in May 17.
“Hence, we expect an earnings turnaround in FY18F,” it said.
The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.
Related Stocks
Comments